# Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications

> **NCT05046301** · — · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 59 (actual)

## Conditions studied

- Breast Carcinoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Contrast Agent
- **PROCEDURE:** Contrast-Enhanced Mammography
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT05046301
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-23
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-02-02
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05046301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05046301, "Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05046301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*